Directory
>
Charles O'neill
Charles O'neill
CoFounder and Chairman of the Board of Directors | OSOD, Ocular Services On Demand
Sonoma, California, United States
Charles O'neill
Summary
Charles O'Neill is an accomplished Consulting Nonclinical Drug Developer and Life Science Investor with a robust background in pharmaceuticals and biotechnology. He has co-founded and led several companies, including Mcal Therapeutics and Black Sheep Ventures, focusing on innovative therapies for various medical conditions. With extensive experience at renowned organizations like BioMarin Pharmaceutical and Genentech, Charles has a proven track record in pharmacological sciences and drug development. He holds a Ph.D. in Pharmacology and Toxicology from the University of California, Davis, and a B.S. in Biology from the University of Redlands. His expertise extends to consulting for life science companies, emphasizing nonclinical development and investment strategies. Charles is passionate about advancing therapeutic solutions and has a keen interest in the intersection of science and business. He is also known for fostering collaboration among experts in the field to drive innovation.
Charles O'neill
Work Experience
CoFounder and Chairman of the Board of Directors at
Mcal Therapeutics
February 2019 - Present
Founder and Managing Director at
Black Sheep Ventures
June 2014 - Present
Consulting Executive Director and Board Member at
OSOD, Ocular Services On Demand
February 2014 - Present
VP Pharmacological Sciences at
Biomarin Pharmaceutical
April 2003 - May 2023
Co-Founder at
SARcode Bioscience Inc.
January 2006 - April 2013
Sr. Scientist at
Genentech
January 1995 - January 2003
Assistant Research Professor at
UC Davis Health
January 1994 - January 1995
Post-Doctoral Fellow at
The National Institutes of Health
January 1992 - January 1994
VP, Pharmacological Sciences at
BioMarin Pharmaceutical Inc.
June 2023
Charles O'neill
Education
University of California, Davis, Ph.D.
January 1987 - January 1992
University of Redlands, B.S.
January 1981 - January 1985
Frequently Asked Questions about Charles O'neill
What is Charles O'neill email address?
Charles O'neill's primary email address is *******@ocularservices.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Charles O'neill work for?
Charles O'neill is a CoFounder and Chairman of the Board of Directors at OSOD, Ocular Services On Demand, a company specializing in Biological products, except diagnostic.
Where Charles O'neill graduated from?
Charles O'neill holds a degree in Pharmacology And Toxicology from University of California, Davis.
How can I directly contact Charles O'neill?
To contact Charles O'neill directly, you can use the email address *******@ocularservices.com. Complete contact information is available upon registration with Muraena.
Who is Charles O'neill?
Charles O'Neill is an accomplished Consulting Nonclinical Drug Developer and Life Science Investor with a robust background in pharmaceuticals and biotechnology. He has co-founded and led several companies, including Mcal Therapeutics and Black Sheep Ventures, focusing on innovative therapies for various medical conditions. With extensive experience at renowned organizations like BioMarin Pharmaceutical and Genentech, Charles has a proven track record in pharmacological sciences and drug development. He holds a Ph.D. in Pharmacology and Toxicology from the University of California, Davis, and a B.S. in Biology from the University of Redlands. His expertise extends to consulting for life science companies, emphasizing nonclinical development and investment strategies. Charles is passionate about advancing therapeutic solutions and has a keen interest in the intersection of science and business. He is also known for fostering collaboration among experts in the field to drive innovation.
Charles`s contact details
*******@ocularservices.com
Colleagues
Co-Founder